About
Titles
Hospital Resident
Biography
Idil Eroglu is a resident physician at Yale-New Haven Hospital in the Internal Medicine Traditional residency program. She completed her undergraduate degree in bioengineering at the University of California, San Diego, and medical school at Weill Cornell Medical College in New York city. Her professional interests include medical education and clinical research in rheumatology. Outside of the hospital, she enjoys spending time outdoors at nearby state parks.
Education & Training
- MD
- Weill Cornell Medical College (2022)
- BSc
- University of California, San Diego, Bioengineering: Biotechnology (2017)
Research
Research at a Glance
Publications Timeline
A big-picture view of Idil Eroglu's research output by year.
4Publications
8Citations
Publications
2022
How Often Do Sentinel Lymph Node Biopsy Results Affect Adjuvant Therapy Decisions Among Postmenopausal Women with Early-Stage HR+/HER2− Breast Cancer in the Post-RxPONDER Era?
Pilewskie M, Sevilimedu V, Eroglu I, Le T, Wang R, Morrow M, Braunstein LZ. How Often Do Sentinel Lymph Node Biopsy Results Affect Adjuvant Therapy Decisions Among Postmenopausal Women with Early-Stage HR+/HER2− Breast Cancer in the Post-RxPONDER Era? Annals Of Surgical Oncology 2022, 29: 6267-6273. PMID: 35849294, PMCID: PMC10286823, DOI: 10.1245/s10434-022-12193-w.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsSentinel lymph node biopsyAxillary lymph node dissectionAdjuvant therapy decisionsPostmenopausal womenNodal irradiationRecurrence scoreBreast cancerPositive nodesTherapy decisionsMedian age 62 yearsOncotype DX recurrence scorePT2-3 tumorsLymph node dissectionLymph node biopsyLow recurrence scoreAge 62 yearsDX recurrence scoreCT1-2N0MethodsPostmenopausal womenNodal pathologyPN0 stagePositive SLNRxPONDER trialAxillary stagingNode dissectionSafety and efficacy of an outpatient 12-step desensitization protocol for antineoplastic agents
Eroglu I, Filippova OT, Kirrane M, Orpen M, Almonte V, Thomas R, Lee-Teh M, Tizon R, Sklarin N, O’Cearbhaill R. Safety and efficacy of an outpatient 12-step desensitization protocol for antineoplastic agents. International Journal Of Gynecological Cancer 2022, 32: 1056-1062. PMID: 35675969, PMCID: PMC9924431, DOI: 10.1136/ijgc-2022-003466.Peer-Reviewed Original ResearchAltmetricConceptsDesensitization protocolHypersensitivity reactionsInfusion timeAntineoplastic agentsCycles of therapyExtended infusion timeMedian infusion timePrior hypersensitivity reactionLeukotriene receptor antagonistsProgression of diseaseEligible patientsSuccessful desensitizationMedian ageRetrospective reviewColorectal cancerInpatient admissionsAntineoplastic therapyReceptor antagonistPatient outcomesLiposomal doxorubicinOvarian cancerMedian numberPatientsSpecific agentsDesensitizationAccuracy of the Breast Cancer Surveillance Consortium Model Among Women with LCIS
Eroglu I, Sevilimedu V, Park A, King TA, Pilewskie ML. Accuracy of the Breast Cancer Surveillance Consortium Model Among Women with LCIS. Breast Cancer Research And Treatment 2022, 194: 257-264. PMID: 35595928, PMCID: PMC10229518, DOI: 10.1007/s10549-021-06499-8.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsInvasive breast cancer riskBreast cancer riskBCSC modelBreast cancerCancer riskBreast densityPrior breast cancerBenign breast diseaseInvasive breast cancerKaplan-Meier methodTime-dependent receiverChemoprevention useCumulative incidenceInvasive cancerLobular carcinomaBreast diseaseIncidence rateFamily historyRisk scoreFair discriminationLCISCancerWomenRisk predictionConsortium model
2021
Ultrasound detection rates of the placenta accreta spectrum with prior myomectomy.
Khander A, Sharma N, Eroglu I, Chasen ST. Ultrasound detection rates of the placenta accreta spectrum with prior myomectomy. The Journal Of Maternal-fetal & Neonatal Medicine : The Official Journal Of The European Association Of Perinatal Medicine, The Federation Of Asia And Oceania Perinatal Societies, The International Society Of Perinatal Obstetricians 2021, 1-4. PMID: 34763606, DOI: 10.1080/14767058.2021.2001800.Peer-Reviewed Original Research
Get In Touch
Contacts
Email